Full Press Release Details
Lexaria Bioscience and Hill Street Beverage Company Announce
Definitive Agreement for
Cannabis-Infused Beverages
Kelowna, British Columbia and Toronto, Ontario July 31,
2018 Lexaria Bioscience Corp. (OTCQX: LXRP; CSE: LXX; the Company or
Lexaria ), a drug delivery platform innovator, and Hill Street Beverage Company
Inc., (TSXV:BEER; Hill Street ) jointly announced that they have signed a
Definitive Agreement to license Lexaria s DehydraTECHTM, on a
semi-exclusive basis, for a term of five (5) years, to produce a line of
cannabis-infused alcohol-free beverages for Canadian distribution, following
regulatory approval. The Definitive Agreement is the conclusion of the process
begun following the announcement of the non-binding letter of intent in April 2018. Terms of the Definitive
Agreement were not disclosed.
US$56,250 (CDN$ 73,497), representing a portion of the
compensation payable to Lexaria, shall be paid and satisfied in common shares in
the capital of Hill Street, at a purchase price of CDN$0.175, for an aggregate
of 419,982 common shares (the Compensation Shares ). The issuance of the
Compensation Shares is subject to regulatory approval, including without
limitation, the approval of the TSX Venture Exchange.
Lexaria s beverage formulation adaptations use patented
technology to act quickly, but without adding any taste or odour, thereby
delivering predictable experiences that dissipate more quickly than many other
cannabinoid edible products. Lexaria has already lab-tested Hill Street s
alcohol-free red and white wines to formulate cannabinoid-fortified wines, and
such tests show virtually zero cannabis taste or odour.
Hill Street CEO, Terry Donnelly, stated, Our goal is to
provide traditional beer and wine drinkers with great tasting products that use
cannabis to mimic the onset and duration of effect that has historically come
from alcohol, but without alcohol s toxicity and added calories. While the early
versions of our wines infused with Lexaria s process have shown great promise,
we are extremely excited about the progress Lexaria continues to make with their
infusion technologies. Lexaria has already demonstrated its importance to our
model as a key strategic partner in our business, and this agreement secures our
future together. As Hill Street s progress into producing the world s finest
alcohol-free and cannabis-infused beverages continues, Lexaria has demonstrated
that they will continue to innovate and improve on their process. This will help
to ensure Hill Street is always at the forefront of producing world-class wine,
beer and other adult format beverages.
Chris Bunka, CEO of Lexaria stated, Hill Street s
award-winning and great-tasting wines and beers need an odourless and tasteless
infusion process like our powerful DehydraTECHTM platform to ensure
they will remain that way after the inclusion of cannabis. Our proven ability to
render full spectrum cannabis and hemp oil into a water-soluble ingredient with
no impact on the taste and smell of complex beverages like wine enables Hill
Street to produce adult format beverages that will give consumers the
recreational experience of cannabis, while enjoying tastes and experiences
consistent with consuming traditional wine, beer and other adult format
About Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE:
Lexaria Bioscience Corp. licenses disruptive patented delivery
technology that promotes healthier ingestion methods, lower overall dosing and
higher effectiveness of lipophilic active molecules. Lexaria has multiple
patents pending in over 40 countries around the world and has patents granted
in the USA and in Australia for utilization of its
DehydraTECHTM delivery technology. Lexaria s technology provides increases in
intestinal absorption rates; more rapid delivery to the bloodstream; and
important taste-masking benefits, for orally administered bioactive molecules
including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules.
For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp
and on Facebook https://www.facebook.com/lexariabioscience/
FURTHER INFORMATION PLEASE CONTACT:
Lexaria Bioscience Corp.
Blanchard, Communications Manager
About Hill Street Beverage Company Inc. (TSXV:BEER)
Founded in 2008, Hill Street Beverage Company is the world's most
award-winning company exclusively focused on alcohol-free beer, wines, and adult
format beverages. Hill Street products include: Vin(Zero) wines, Vintense wines,
Hill Street Craft Brewed Lager, and Designated Draft beer. Hill Street s
award-winning products have won the Retail Council of Canada's Grand Prix, and
numerous medals and accolades including three Gold, two Silver, and two Bronze
Medals at the U.S. Open Beer Championships, and a prestigious Double Gold Medal
at the San Francisco International Wine Challenge. As a result of the Royal
Assent of Canada s Bill C-45, legislation to allow the sale of cannabis-infused
beverages is to occur by October 17, 2019. Hill Street is currently applying for
appropriate licenses to permit the production and sale of cannabis infused
beverages in Canada, with the view of having infused products available for sale
once the regulations permit.
For further information:
Chairman and CEO, Hill Street Beverage Company Inc.,
terry@hillstreetbevco.com, (416) 543-4904;
Gareth Tingling, Investor
gareth@sophiccapital.com, (647) 797-0219
Follow Hill Street on Twitter https://twitter.com/hillstreetbevco
and on Facebook http://facebook.com/hillstreetbevco
FORWARD-LOOKING STATEMENTS
includes forward-looking statements. Statements which are not historical facts
are forward-looking statements. Any references made by either company mentioned
in this press release regarding forward-looking public statements concerning
expected future financial position, results of operations, cash flows, financing
plans, business strategy, products and services, competitive positions, growth
opportunities, plans and objectives of management for future operations,
including statements that include words such as "anticipate," "if," "believe,"
"plan," "estimate," "expect," project , "intend," "may," "could," "should,"
"will," and other similar expressions are forward-looking statements, including
but not limited to: that any additional patent protection will be realized or
that patent achievements will deliver material results. Such forward-looking
statements are estimates reflecting either company s best judgment based upon